Introduction {#s1}
============

Infection of livestock by African trypanosomes has a significant effect on food production in sub-Saharan Africa ([@bib43]). In contrast to human disease, which is caused by a restricted set of subspecies of *Trypanosoma brucei* ([@bib30]; [@bib33]), livestock disease is caused by at least six distinct species of African trypanosome, the most prevalent being *T. congolense* and *T. vivax* ([@bib40]). While all share some common features, including antigenic variation and transmission by the tsetse fly, one of the most obvious differences between species is variation in the developmental cycle in the fly ([@bib21]) and in particular the location of the epimastigote developmental stage. *T. brucei* epimastigotes attach to the epithelium in the salivary glands away from the digestive tract, whereas *T. congolense* and *T. vivax* attach in the proboscis within the digestive tract ([@bib21]; [@bib34]; [@bib25]). The basis for these different tissue tropisms is not known.

The cell surface of an African trypanosome acts as the molecular interface with its host, and the developmental transitions of the life cycle involve radical changes in cell surface composition, presumably as adaptations to different host niches. The best understood stage is the mammalian bloodstream form where the cell surface is covered with a dense layer of variant surface glycoprotein (VSG), which acts to protect the plasma membrane, enhancing survival of individual cells and allowing antigenic variation to ensure population survival ([@bib41]; [@bib22]). The density of packing of the VSG molecules on the surface of the bloodstream form trypanosome is thought to approach the maximum possible ([@bib16]). In contrast, the developmental stages found inside insects, including the procyclic and epimastigote forms, have less densely packed surface coats, and contain different sets of surface proteins, including GARP in *T. congolense* and procyclins and BARP in *T. brucei* ([@bib2]; [@bib39]; [@bib49]; [@bib3]). Other cell surface proteins, including receptors and transporters, must operate in the context of these different cell surface architectures ([@bib29]; [@bib46]).

The haptoglobin-haemoglobin receptor of *Trypanosoma brucei* (TbHpHbR) is the best characterised trypanosome receptor. It is expressed in the mammalian bloodstream form and is used for the uptake of haptoglobin-haemoglobin complexes (HpHb) for haem acquisition ([@bib51]). In humans and some other primates, TbHpHbR also plays a role in innate immunity. Human serum contains two complexes, trypanolytic factors-1 and -2 (TLF1 and TLF2), which cause trypanosome lysis ([@bib38]; [@bib17]; [@bib48]; [@bib37]). TLF1 and TLF2 both contain the apolipoprotein L1 toxin ([@bib50]) and a complex of haemoglobin bound to haptoglobin-related protein (HprHb) ([@bib37]). It is the binding of HprHb to TbHpHbR that provides the uptake route for TLF1 into the trypanosome ([@bib51]).

High-resolution structures of TbHpHbR, both alone and in complex with HpHb, have shown how it can function within the densely packed VSG layer ([@bib29]; [@bib46]). The N-terminal domain of TbHpHbR is formed from an extended three α-helical bundle with a small, membrane-distal head, and is attached to the plasma membrane by a glycophosphatidylinosotol-anchor at the C-terminus of a small C-terminal domain. HpHb binds along the membrane-distal half of the helical bundle. A striking feature of this helical bundle is a \~50° kink, which lies between the HpHb binding site and the membrane attachment point. This kink is likely to result in separation of the VSG molecules on either side of the receptor, holding them apart and presenting the HpHb binding site to the extracellular environment. It also allows two receptors to contact a single HpHb dimer, allowing greater avidity for the ligand and more efficient uptake into trypanosomes ([@bib29]). Specificity for HpHb results from direct, simultaneous contact between the receptor and both haptoglobin and the β-subunit of haemoglobin. Neither isolated haemoglobin nor haptoglobin binds significantly ([@bib51]). In addition, the propionate chains of haem directly contact the receptor and contribute to binding, with a significant reduction in binding affinity for HpHb that lacks haem ([@bib46]). Therefore TbHpHbR has evolved specific adaptations to function in the context of the VSG layer and to selectively bind to haem-loaded HpHb complexes.

The *T. congolense* receptor (TcHpHbR) was identified by sequence homology to the receptor from *T. brucei* and also binds to HpHb with low micromolar affinity (a K~D~ of 8 μM for TcHpHbR compared with 1 μM for TbHpHb) ([@bib19]). Mutagenesis studies showed that TcHpHbR and TbHpHbR use overlapping binding sites to interact with HpHb ([@bib19]). The structure of TcHpHbR has a similar architecture to TbHpHbR, with a long three α-helical bundle and small membrane-distal head. However, one striking difference is that the helical bundle of TcHpHbR lacks the kink found in TbHpHbR. With the kink suggested to play a critical role in the operation of TbHpHbR in the context of the VSG layer, it was surprising that TcHpHbR lacks this evolutionary adaption if it too operates in a similar, densely packed environment. For this reason, we set out to investigate the structure and function of the *T. congolense* HpHbR, to understand its ligand binding specificity, its site of action and the evolutionary adaptations undergone by haptoglobin-haemoglobin receptors from different species.

Results {#s2}
=======

The *T. brucei* haptoglobin-haemoglobin receptor has evolved from a haemoglobin receptor {#s2-1}
----------------------------------------------------------------------------------------

To gain an understanding of ligand binding by TcHpHbR, we aimed to determine its structure in complex with HpHb. Human haemoglobin in complex with the SP domain of human haptoglobin (HpSP) was mixed with a small molar excess of TcHpHbR prior to gel filtration chromatography, in order to purify receptor-ligand complex. However, analysis of the resulting fractions from the chromatography column revealed a higher molecular weight peak containing TcHpHbR and Hb, but no HpSP. A lower molecular weight peak, at the elution volume expected for unliganded TcHpHbR, contained excess free TcHpHbR and HpSP ([Figure 1A](#fig1){ref-type="fig"}). Therefore the presence of TcHpHbR led to disassembly of the HpSPHb complex and the formation of a complex containing TcHpHbR and Hb.10.7554/eLife.13044.003Figure 1.*T. congolense* and *T. vivax* HpHbRs are haemoglobin receptors.(**A**) Analytical gel filtration chromatography analysis showing the consequence of mixing HpSPHb and TcHpHbR. A mixture of TcHpHbR and HpSPHb was loaded onto the column, resulting in two peaks. The gel shows that peak 1 contains a complex of TcHpHbR bound to Hb, while peak 2 contains free TcHpHbR and free HpSP. (**B**) Surface plasmon resonance analysis of the binding of HpHbRs from *T. b. brucei, T. congolense* and *T. vivax* to either Hb or HpHb. (**C**) Isothermal titration calorimetry shows the binding of two TcHpHbR to one Hb tetramer. (**D**) A phylogenetic tree indicating the evolutionary history of the trypanosome strains under study ([@bib45]).**DOI:** [http://dx.doi.org/10.7554/eLife.13044.003](10.7554/eLife.13044.003)10.7554/eLife.13044.004Figure 1---figure supplement 1.TcHpHbR does not disassemble HpHb.(**A**) Analytical gel filtration chromatography analysis showing the consequence of mixing HpHb and TcHpHbR. A mixture of TcHpHbR and HpHb was loaded onto the column, resulting in two peaks. The gel shows that peak 1 contains HpHb while peak 2 contains free TcHpHbR. This shows that TcHpHbR did not disassemble HpHb and that the TcHpHbR:HpHb affinity is not sufficient for the complex to remain stable during the course of a gel filtration experiment. (**B**) Analytical gel filtration chromatography analysis showing the consequence of mixing Hb and TcHpHbR. A mixture of TcHpHbR and Hb was loaded onto the column, resulting in two peaks. The gel shows that peak 1 contains the TcHpHbR:Hb complex while peak 2 contains free TcHpHbR, showing the formation of a stable complex.**DOI:** [http://dx.doi.org/10.7554/eLife.13044.004](10.7554/eLife.13044.004)10.7554/eLife.13044.005Figure 1---figure supplement 2.TcHpHbR binding to bovine Hb.Surface plasmon resonance analysis of the binding of *T. congolense* HpHbR to bovine Hb.**DOI:** [http://dx.doi.org/10.7554/eLife.13044.005](10.7554/eLife.13044.005)

While native haptoglobin is cleaved to form α- and β-subunits, the recombinant HpSP used in this study is not cleaved. We therefore repeated the gel filtration experiment using native Hp in an HpHb complex. In this case, we found that the HpHb complex is not disassembled by incubation with the receptor, suggesting that the receptor does not disassemble native HpHb complexes during its physiological function ([Figure 1---figure supplement 1A](#fig1s1){ref-type="fig"}). However, the complex that it forms with the receptor is not sufficiently strong to remain intact during gel filtration chromatography and HpHb and the receptor elute in separate peaks, confirming that the receptor has a low affinity for HpHb.

The discovery that TcHpHbR binds to Hb was unexpected as TbHpHbR had previously been shown to bind HpHb but not to free Hb ([@bib51]). Surface plasmon resonance (SPR) was therefore used to investigate the ligand specificity of HpHbRs from *T. brucei, T. congolense* and *T. vivax.* The receptors were immobilised on the chip surface through a C-terminal biotin moiety, causing them to be presented in the same orientation as on the cell surface. Binding was then measured for both Hb and HpHb. As expected, HpHbR from *T. brucei* interacted with HpHb, but not with Hb alone ([Figure 1B](#fig1){ref-type="fig"}). However, HpHbRs from both *T. congolense* and *T. vivax* interacted with either HpHb or free Hb. Indeed, both receptors formed a far more stable complex with Hb than with HpHb, as shown by the lower off-rate ([Figure 1B](#fig1){ref-type="fig"}). In addition when Hb was mixed with TcHpHbR and subjected to gel filtration chromatography, the primary peak was a complex of TcHpHbR bound to Hb, indicating that TcHpHbR forms a more stable complex with Hb than with HpHb ([Figure 1---figure supplement 1B](#fig1s1){ref-type="fig"}).

*T. congolense* is not a human infective pathogen, but is found in numerous livestock species. We therefore also tested the binding of TcHpHbR to bovine haemoglobin and observed a strong interaction with a slow off rate ([Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). Therefore TcHpHbR has a high affinity for Hb, while TbHpHbR does not bind to Hb alone. A similar change in specificity is seen in the mammalian scavenger receptor CD163, as mouse CD163 binds to Hb while human CD163 binds to HpHb alone ([@bib11]).

As haemoglobin is a symmetrical tetramer of two α and two β subunits, each tetramer could potentially bind to two receptors and the SPR measurements described above would result from a mixture of monovalent and bivalent binding. Isothermal titration calorimetry (ITC) was therefore used to measure the monovalent K~D~ and the stoichiometry of the interaction between TcHpHbR and Hb ([Figure 1C](#fig1){ref-type="fig"}). This revealed that two receptors interact with one Hb tetramer. This follows the same pattern as the TbHpHbR:HpHb complex, where two receptors bind to each dimeric HpHb complex ([@bib29]; [@bib46]). The K~D~ for the TcHpHbR:Hb interaction was estimated to be 3 nM by ITC. This is around 1000-fold tighter than the affinity of the same receptor for HpHb, previously measured by ITC to be 3 μM ([@bib19]).

*T. congolense* and *T. brucei* diverged from each other after their last common ancestor had diverged from *T. vivax* ([Figure 1D](#fig1){ref-type="fig"}) ([@bib44]; [@bib18]; [@bib26]). As HpHbRs from both *T. congolense* and *T. vivax* bind to Hb, it is most likely that this property was lost from *T. brucei* after it diverged from *T. congolense* rather than separately gained in both *T. congolense* and *T. vivax*. The \~1000-fold higher affinity of TcHpHbR for Hb than for HpHb also suggests that Hb binding is the major evolved function of this receptor in *T. congolense* and *T. vivax*. Together these observations suggest that the ancestor of the HpHbRs was primarily a haemoglobin receptor and that evolutionary changes that have taken place during the evolution of *T. brucei* have led to an alteration in its binding specificity.

The haptoglobin-haemoglobin receptor of *T. congolense* is expressed in the epimastigote developmental stage {#s2-2}
------------------------------------------------------------------------------------------------------------

The finding that TcHpHbR is a haemoglobin receptor was unexpected in the light of our current knowledge of TbHpHbR. In *T. brucei*, the receptor is expressed in the mammalian bloodstream stage of the parasite, where it functions in the acquisition of haem as a nutrient ([@bib51]). In mammalian blood, free haemoglobin levels are extremely low due to the presence of haptoglobin as a scavenger. Haptoglobin binds free Hb, allowing it to be removed from the serum by endocytosis of HpHb complexes into macrophages, reducing the potential for oxidative damage caused by haem ([@bib27]). Therefore, except under conditions of exceptional haemolysis, there is little haemoglobin present in the blood, bringing into question the requirement for a haemoglobin receptor. We therefore assessed the life cycle stage of *T. congolense* in which the receptor is expressed.

While *T. congolense* will not be exposed to free haemoglobin in the mammalian bloodstream, developmental forms in the tsetse fly will be exposed to haemoglobin derived from the bloodmeal. A previous proteomic analysis comparing different developmental stages of *T. congolense* did not detect TcHpHbR protein in bloodstream forms but did detect it as an abundant protein in epimastigotes ([@bib13]). In addition, a transcriptome analysis of various developmental forms of *T. vivax* indicated that TvHpHbR mRNA was most abundant in epimastigotes ([@bib24]). To investigate further, *T. congolense* epimastigotes were generated from procyclic form cultures ([@bib6]). Western blot analysis of three independently generated epimastigote-containing cultures showed expression of the TcHpHbR in these populations, while expression was below detectable levels in the original procyclic cells or in bloodstream form *T. congolense* ([Figure 2](#fig2){ref-type="fig"}; [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Therefore differentiation to the epimastigote form was associated with expression of TcHpHbR.10.7554/eLife.13044.006Figure 2.Western analysis reveals high levels of HpHbR expression in epimastigote-enriched cultures.(**A**) Three populations of *T. congolense* epimastigotes were generated in vitro by maintaining procyclic form cultures of *T. congolense* IL3000 cells at stationary phase ([@bib6]). The majority of epimastigote forms are adherent and stick to the culture flask while the culture supernatant is predominantly trypomastigotes with a low percentage of detached epimastigote forms. Cell lysates where generated from culture supernatants and subject to western blot analysis. No TcHpHbR protein expression was detected in procyclic form cultures (PCF) whereas TcHpHbR expression was observed in all epimastigote-containing cultures. The protein is observed above the expected 32 kDa, probably due to the GPI-anchor and N-glycosylation affecting mobility as has been observed for the TbHpHbR ([@bib51]). Loading control is anti-TbPRF2. (**B**) No TcHpHbR protein expression was detected in *T. congolense* bloodstream forms (BSF) or procyclic form cultures (PCF) by western blot, whereas expression was detected in epimastigote-containing cultures (Epi).**DOI:** [http://dx.doi.org/10.7554/eLife.13044.006](10.7554/eLife.13044.006)10.7554/eLife.13044.007Figure 2---figure supplement 1.Validation of TcHpHbR antisera and quantification of TcHpHbR protein expression in *T. congolense* epimastigotes.(**A**) Antisera was raised and purified against recombinant TcHpHbR. The antisera recognized two bands in *T. congolense* epimastigotes that run at a higher molecular weight on an acrylamide gel, as expected of a GPI-anchored and N-glycosylated protein and as observed for the TbHpHbR in *T. brucei* bloodstream forms, BSFs ([@bib51]), with the largest band representing the fully processed form of the protein. To confirm this was indeed the TcHpHbR, *T. brucei* TbHpHbR KO cells were transfected with an inducible copy of the TcHpHbR in an over-expression vector. Upon induction with doxycycline (Dox), the antisera detected two bands that again ran at a higher molecular weight than the recombinant TcHpHbR. While the upper band represents the minority of protein in this case, this is probably due to differential modification of the GPI-anchor in bloodstream and insect cell forms ([@bib14]). (**B**) Known quantities of recombinant TcHpHbR protein were loaded next to known numbers of TcHpHbR expressing cell equivalents (calculated by IFA analysis on mixed epimastigote and procyclic populations). By two independent western blots 8.35 x 10^4^ cell equivalents was estimated to be equivalent to between 2.25 and 4.5 ng of recombinant protein (an average of between 5 and 9 x 10^5^ molcules per cell).**DOI:** [http://dx.doi.org/10.7554/eLife.13044.007](10.7554/eLife.13044.007)

Immunofluorescence analysis (IFA) was carried out next to determine the sub-cellular localisation of TcHpHbR using epimastigote forms generated in vitro from procyclic form cultures. The key distinguishing feature resulting from differentiation to epimastigotes is a change in the relative positions of the nucleus and kinetoplast along the anterior-posterior axis of the cell. In trypomastigote forms, such as procyclics, the kinetoplast is positioned posterior to the nucleus while in epimastigote forms it is juxtanuclear or anterior to the nucleus ([@bib34]; [@bib52]). In all cells in which kinetoplast repositioning to that found in the epimastigote form had occurred, TcHpHbR protein was detected and localised across the whole cell surface, including the flagellum, in both permeabilised and non-permeabilised cells ([Figure 3A and B](#fig3){ref-type="fig"}).10.7554/eLife.13044.008Figure 3.Immunofluorescent analysis of *T. congolense* epimastigotes reveals TcHpHbR protein is expressed at high levels across the entire cell surface.(**A**) Immunofluorescence analysis of paraformaldehyde-fixed (non-permeabilised) in vitro generated *T.congolense* WG81 epimastigotes with rabbit anti-TcHpHbR antisera and an Alexa488 conjugated anti-rabbit secondary antibody. TcHpHbR was readily detected on the surfaces of all cells where kinetoplast repositioning had occurred. (Arrow highlights a trypomastigote, arrowhead highlights an epimastigote) (**B**) This was also observed with immunofluorescence analysis of methanol-fixed (permeabilised) in vitro generated *T. congolense* Il3000 epimastigotes. Occasionally TcHpHbR expression was detected in cells that did not display kinetoplast repositioning. (Arrow highlights a TcHpHbR positive cell without associated kinetoplast repositioning.) (**C**) *T.congolense* Gam2 cells were harvested from the midgut (top panel), proventriculus (second panel) and proboscis (lower three panels) of tsetse flies. Cells were fixed with methanol and immunofluorescence analysis was carried out as above. Trypanosomes harvested from the midgut (top panel) were always negative for TcHpHbR and those harvested from the proventiculus (second panel) were mostly negative for TcHpHbR, although occasional cells were identified with a faint positive signal. Epimastigotes harvested from the proboscis (lower three panels, arrowheads) were always strongly positive for TcHpHbR. Trypomastigotes from the proboscis (lower three panels, arrows) showed a faint or negative signal for TcHpHbR (arrows). All scale bars represents 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.13044.008](10.7554/eLife.13044.008)10.7554/eLife.13044.009Figure 3---figure supplement 1.TcHpHbR is expressed on a cell undergoing asymmetric division.A TcHpHbR-expressing cell was identified that was undergoing asymmetric division, where one daughter cell will be an epimastigote and the other will be a trypomastigote, as occurs during metacyclogenesis in *T. brucei.* Scale bar represents 10 µm.**DOI:** [http://dx.doi.org/10.7554/eLife.13044.009](10.7554/eLife.13044.009)

A minority of cells that expressed TcHpHbR did not have the characteristic kinetoplast and nuclear positioning characteristic of epimastigotes ([Figure 3B](#fig3){ref-type="fig"}, arrow). This observation may indicate that: (i) TcHpHbR expression in epimastigotes occurs immediately prior to kinetoplast repositioning, and/or (ii) epimastigote formation in vitro is incomplete and/or (iii) the epimastigotes were differentiating further into metacyclic forms and that these, at least initially, retain TcHpHbR expression. The last possibility is supported by the identification of a TcHpHbR-expressing cell undergoing asymmetric division, where one daughter cell will be an epimastigote and the other will not, as occurs during metacyclogenesis in *T. brucei* ([@bib40]) ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) and by the proteomic detection of low levels of TcHpHbR in metacyclic populations ([@bib13]).

To confirm that the TcHpHbR is indeed an epimastigote-stage protein in vivo, *Glossina pallidipes* tsetse flies were infected with *T. congolense* Gam2. Trypanosomes were harvested from the midgut, proventriculus and proboscis of infected flies 40 days post infection and expression of TcHpHbR was investigated by immunofluorescence. Trypomastigote forms harvested from the midgut (procyclics) were all negative for TcHpHbR staining ([Figure 3C](#fig3){ref-type="fig"}, top panel). Trypomastigotes from the proventriculus were also typically negative for TcHpHbR staining ([Figure 3C](#fig3){ref-type="fig"}, second panel), although some cells were identified with faint positive signal (data not shown). Trypanosomes collected from the tsetse proboscis included both trypomastigotes (proventricular trypomastigotes, pre-metacyclics or metacyclic forms) and epimastigotes ([Figure 3C](#fig3){ref-type="fig"}, lower three panels, arrows highlight trypomastigotes and arrowheads highlight epimastigotes). All epimastigotes identified had high levels of TcHpHbR expression, whereas trypomastigotes were either negative or weakly positive ([Figure 3C](#fig3){ref-type="fig"}, lower three panels). Therefore, TcHpHbR is highly expressed in the *T. congolense* epimastigote life-stage in vivo, with some upregulation of expression occurring prior to kinetoplast repositioning.

TcHpHbR expression was readily detected over the entire cell surface of epimastigotes, suggesting expression levels were higher than those of receptors previously characterized in bloodstream forms of *T. brucei*. The average copy number of TcHpHbR was therefore estimated using western blots to compare cell lysates from in vitro generated epimastigotes with known quantities of recombinant protein, with an adjustment for the percentage of cells in the culture expressing the protein as determined by immunofluorescence. This suggested an average of \~5--9 x 10^5^ TcHpHbR molecules to be present per TcHpHbR-expressing cell ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). For comparison, *T. brucei* bloodstream forms express approximately 200 to 400 TbHpHbR molecules per cell ([@bib51]; [@bib9]). Therefore the *T. congolense* HpHbR is an abundant protein expressed in epimastigotes, with around a 1000-fold more receptors per cell than are found in the *T. brucei* bloodstream form.

*T. congolense* epimastigotes internalise haemoglobin {#s2-3}
-----------------------------------------------------

To determine if TcHpHbR functioned in receptor-mediated endocytosis of Hb, ligand uptake was monitored in a live cell assay using culture-derived epimastigotes of *T. congolense* WG81. These cultures contained both trypomastigotes and epimastigotes. The trypanosomes were incubated with either 10 nM Alexa488-labelled Hb or 10 nM Alexa488-labelled BSA. Internalisation of Hb, but not BSA, was observed specifically in epimastigote forms but not in trypomastigote forms ([Figure 4](#fig4){ref-type="fig"}). Therefore, the *T. congolense* developmental form that highly expresses the TcHpHbR on its surface is indeed able to internalise Hb at low nanomolar concentrations.10.7554/eLife.13044.010Figure 4.*T. congolense* epimastigotes internalise 488-labelled Hb.Assay for uptake of Alexa488-labelled Hb (Hb-488) and Alexa488-labelled BSA (BSA-488) into *T. congolense* WG81 epimastigotes was monitored by microscopy. Uptake of Hb-488 was detected at 10 nM in epimastigotes (lower panel, arrowheads) but not in trypomastigotes (lower panel, arrow). No fluid phase uptake of BSA-488 at 10 nM in any cells (centre panel).**DOI:** [http://dx.doi.org/10.7554/eLife.13044.010](10.7554/eLife.13044.010)

The structural basis for haemoglobin binding {#s2-4}
--------------------------------------------

To investigate the molecular basis for haemoglobin binding by TcHpHbR, we mixed the receptor with HpSPHb. As described above ([Figure 1A](#fig1){ref-type="fig"}), this generated a complex of TcHpHbR bound to Hb. This complex crystallised with a well solution of 8% PEG 8000, 0.1 M sodium citrate pH 5.0 in 18 hr, and a complete data set was collected to 3.2 Å resolution. A molecular replacement solution was determined using *T. congolense* HpHbR (pdb: 4E40) and human Hb (pdb: 1HHO) as search models. This allowed placement of two receptor molecules and a single haemoglobin tetramer in the asymmetric unit of the crystal ([Figure 5](#fig5){ref-type="fig"}, [Table 1](#tbl1){ref-type="table"}). Each receptor makes the same interactions with haemoglobin, and the receptor conformation is unaltered from that of unliganded receptor ([@bib19]), with a root-mean-square deviation of 0.6 Å. This lack of conformational change on ligand binding matches that seen in the structures of *T. brucei* HpHbR alone and in the presence of HpHb ([@bib29]). The haemoglobin is in the oxygenated conformation with a root-mean-square deviation of 0.7 Å from the search model.10.7554/eLife.13044.011Figure 5.The structural basis of haemoglobin binding by TcHpHbR.(**A**) The structure of a complex of TcHpHbR bound to Hb. (**B**) The structure of the TbHpHbR:HpSPHb complex ([@bib29]). (**C**) The contents of the asymmetric unit of the TcHpHbR:Hb crystals, showing two receptors binding to a single haemoglobin tetramer. (**D**) A close up view of the interaction of TcHpHbR with the β-chain of haemoglobin showing the direct contacts made with the haem group. (**E**) A close up view of the interaction of TcHpHbR with the α-chain of haemoglobin showing the direct contacts made with the haem group.**DOI:** [http://dx.doi.org/10.7554/eLife.13044.011](10.7554/eLife.13044.011)10.7554/eLife.13044.012Figure 5---figure supplement 1.TcHpHbR-binding residues are conserved across mammalian haemoglobins.Residues in green interact with TcHpHbR in the TcHpHbR:Hb structure. Residues in blue interact with TbHpHbR in the TbHpHbR:HpSPHb structure. Residues in orange interact with both TcHpHbR and TbHpHbR. These residues are conserved in human haemoglobin and also in haemoglobins from livestock species that can be infected by *T. congolense.***DOI:** [http://dx.doi.org/10.7554/eLife.13044.012](10.7554/eLife.13044.012)10.7554/eLife.13044.013Table 1.Crystallographic statistics.**DOI:** [http://dx.doi.org/10.7554/eLife.13044.013](10.7554/eLife.13044.013)BeamlineDiamond I03Space GroupP22~1~2~1~Cell parameters (Å)a=72.75, b=127.3, c=172.42Resolution (Å)101.89-3.2Wavelength (Å)0.976*R*~PIM~ (%)7.3 (41.0)I/ σ(I)7.3 (2.4)Completeness (%)99.0 (99.1)Multiplicity2.7 (3.0)Resolution (Å)3.2No. reflections25191R~work~ / R~free~ (%)20.44 / 23.51No. of protein residues in model1063rmsd bond lengths (Å)0.010rmsd bond angles (°)1.21Ramachandran plotPreferred region93.1%Allowed region6.9%Outliers0%

The interaction surface can be divided into two subsites, with interactions made with the α-subunit of one haemoglobin dimer and the β-subunit of the second haemoglobin dimer ([Figure 5A](#fig5){ref-type="fig"}). This suggests that the receptor either binds selectively to haemoglobin tetramers or that two haemoglobin dimers will assemble together with the receptor. All receptor-ligand interactions are mediated by features that are absolutely conserved between haemoglobin from human and livestock species ([Table 2](#tbl2){ref-type="table"}, [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). It is therefore highly likely that the haemoglobin molecules of most of the mammals bitten by tsetse flies will bind to the receptor. The membrane-distal binding site interacts with the α-subunit of haemoglobin ([Figure 5E](#fig5){ref-type="fig"}). This contains more than half of the total interaction surface area (\~735 Å^2^ of 1385 Å^2^). It is predominantly mediated by hydrogen bonds and electrostatic contacts, with a significant component from a direct interaction between the receptor and the propionate chains of haem. This binding site is similar in location, size and chemical nature to the membrane-distal binding site of TbHpHbR for HpHb, in which the same region of TbHpHbR makes direct contacts with the β-subunit of haemoglobin ([Figure 5B](#fig5){ref-type="fig"}).10.7554/eLife.13044.014Table 2.Description of interactions between TcHpHbR and Hb.**DOI:** [http://dx.doi.org/10.7554/eLife.13044.014](10.7554/eLife.13044.014)*Tc*HpHbRHbResidueGroupChainResidueGroupInteractionHbαS29backbone COC/EH46side chainHydrogen bondS29side chainC/EHaemO1Hydrogen bondI30side chainC/EPatchHydrophobicR37side chain NH1/NH2C/EL92backbone COHydrogen bondK127side chainC/EP45backbone COHydrogen bondK130side chainC/EPatchHydrophobicT166side chainC/EHaemO3Hydrogen bondY168side chainC/EPatchHydrophobicY168backbone COC/EK91side chainHydrogen bondD169side chainC/EK91side chainSalt bridgeHbβI41side chainD/FPatchHydrophobicR42side chain NH2D/FHaemO1Hydrogen bondA44side chainD/FPatchHydrophobicT45side chainD/FPatchHydrophobicE47side chain OE2D/FK96side chainSalt bridgeF48side chainD/FPatchHydrophobicK52side chainD/FHaemO3Hydrogen bond

The smaller, membrane-proximal part of the binding site contacts the β-subunit of haemoglobin with a total contact surface area of 650 Å^2^ ([Figure 5D](#fig5){ref-type="fig"}). This interface is more hydrophobic in nature than the membrane-distal site. However, once again, the propionate chains of haem directly interact with the receptor. This membrane distal binding site is distinct in position and chemical nature from the region of TbHpHbR that contacts haptoglobin, which is closer to the membrane surface and is smaller (\~505 Å^2^). The more extensive contact site between TcHpHbR and the β-subunit of Hb, than that between TbHpHbR and Hp, is likely to be a major contributor to the increased affinity of TcHpHbR for Hb.

TcHpHbR also interacts with HpHb, albeit with a significantly lower affinity. To understand the molecular basis for this interaction, we generated a model of the TcHpHbR:HpHb complex ([Figure 6A](#fig6){ref-type="fig"}). One surprise from a comparison of the TcHpHbR:Hb structure with that of TbHpHbR:HpHb is that the membrane distal binding site of TcHpHbR interacts with the Hb α-subunit while the equivalent site of TbHpHbR interacts with the Hb β-subunit of HpHb. We modeled the TcHpHbR:HpHb structure by docking either Hb subunit from the structure of HpHb onto the interacting Hb α-subunit of the TcHpHbR:Hb complex. When the Hb α-subunit is docked onto the membrane-distal binding site, Hp makes no contacts with the receptor. In contrast, when the HpHb is 'flipped' so that the Hb β-subunit contacts the membrane-distal binding site, this positions Hp adjacent to the receptor ([Figure 6A](#fig6){ref-type="fig"}). In addition, the residues from the Hb α-subunit that contact the membrane-distal binding site are replaced by chemically similar residues in the Hb β-subunit, allowing equivalent interactions to occur. The interaction between TbHpHbR and Hp is predominantly hydrophobic in nature, and a similar, but smaller, hydrophobic region in TcHpHbR, involving phenylalanine 48 is similarly positioned to interact with Hp. We therefore predict that HpHb interacts with TcHpHbR with a similar binding mode to that observed in the TbHpHbR:HpHb complex with the Hb β-subunit contacting the membrane-distal binding site, allowing haptoglobin to bind to a membrane-proximal site.10.7554/eLife.13044.015Figure 6.Understanding HpHbR ligand specificity.(**A**) A model of TcHpHbR bound to HpSPHb, based on the TcHpHbR:Hb structure. (**B**, **C**) The TcHpHbR:Hb and TbHpHbR:HpSPHb complexes have been aligned, with the haemoglobin subunit that interacts with the membrane distal binding site used for the alignment. This shows that a change in the path of the helical bundle of TbHpHbR (blue) prevents the interaction that occurs between TcHpHbR (green) and the membrane proximal haemoglobin subunit. This disruption of the membrane proximal binding site has caused TbHpHbR to lose affinity for Hb**DOI:** [http://dx.doi.org/10.7554/eLife.13044.015](10.7554/eLife.13044.015)

Finally, a comparison of the TcHpHbR:Hb structure with that of TbHpHbR:HpHb allows us to rationalise the changes have taken place in TbHpHbR to cause the loss of Hb binding. While an alignment of these structures shows little alteration in the membrane-distal binding site, the path of helix I of the receptor is altered in TbHpHbR so that it no longer forms the membrane-proximal binding site for the Hb β-subunit, thereby reducing the total interaction surface area by nearly half ([Figure 6B and C](#fig6){ref-type="fig"}). This change in the helical pathway could be a consequence of the adoption of a kink in TbHpHbR, which allows the receptor to function in the context of the VSG layer. Alternatively, it could be a result of changes that lead to the increase in the affinity of the receptor for HpHb, from 8 μM in *T. congolense* to 1 µM in *T. brucei,* as determined by SPR ([@bib19]).

Discussion {#s3}
==========

The haptoglobin-haemoglobin receptor of *T. brucei* has been extensively characterised because of its role in the uptake of haptoglobin-haemoglobin into the bloodstream form parasite ([@bib51]; [@bib29]). This receptor also mediates uptake of trypanolytic factor-1 ([@bib51]) and to a lesser extent the uptake of trypanolytic factor-2 ([@bib5]), contributing to the inability of most isolates of *T. brucei* to survive in human serum. It was a reasonable expectation that orthologues in other African trypanosome species, such as *T. congolense* and *T. vivax*, would have a similar function. However, here it is shown that there are significant differences between the receptors from *T. brucei* and *T. congolense*. Firstly, *T. congolense* HpHbR has an approximately 1000-fold greater affinity for haemoglobin than for haptoglobin-haemoglobin and developmental forms expressing TcHpHbR are able to internalise Hb at low nanomolar concentrations. Secondly, the *T. congolense* receptor is expressed in the epimastigotes with a copy number approximately 1000-fold greater than that of *T. brucei* HpHbR in the bloodstream form. Finally, *T. congolense* HpHbR is distributed over the whole cell surface, whereas in *T. brucei* it is concentrated in the flagellar pocket ([@bib51]). Similar findings are seen for *T. vivax*, as TvHpHbR also binds haemoglobin preferentially over haptoglobin-haemoglobin and is, at the mRNA level, preferentially expressed in epimastigotes ([@bib24]). This, together with the evolutionary history of the trypanosomes, suggests that the receptors from *T. vivax* and *T. congolense* represent the ancestral form, while the *T. brucei* receptor has adopted a modified function and cellular distribution.

The location of *T. congolense* epimastigotes in the tsetse fly mouthparts provides the parasite with the opportunity to acquire nutrients from bloodmeals obtained by the fly. The presence of TcHpHbR will allow epimastigotes to scavenge haem that is present in haemoglobin molecules released from lysed erythrocytes, or to bind more weakly to haptoglobin-haemoglobin. It is noteworthy that the predominant form of bovine haptoglobin adopts higher order multimers more complex than the dimeric HpHb used in this study ([@bib28]) and it is possible that this may increase the avidity for TcHpHbR, as observed for multimeric human HpHb binding to scavenger receptor CD163 ([@bib27]), making uptake of HpHb more efficient. Endocytosis of TcHpHbR bound to either Hb or HpHb would then provide the parasite with haem.

The expression level of TcHpHbR in the epimastigote form is surprising, with over 5 x 10^5^ copies per cell. This is approximately 1000-fold greater than the level of TbHpHbR in the bloodstream form ([@bib51]; [@bib9]). One possible explanation for this abundant expression is that the receptor must capture haemoglobin as it periodically and transiently flows over the cell surface when the blood meal passes through the tsetse fly mouthparts. This is in contrast with TbHpHbR expressed in the *T. brucei* bloodstream stage, which will be constantly exposed to its ligand. It remains unknown how *T. congolense* bloodstream forms acquire haem. It may be that sufficient haptoglobin-haemoglobin enters the cell through fluid phase endocytosis or perhaps through an alternative receptor, such as the ortholog of the LHR1 haem transpoter utilized by *Leishmania amazonensis* ([@bib23]).

Our knowledge of the structure and function of HpHbR in both *T. congolense* and *T. brucei* allows us to propose an evolutionary history for the changes that took place in the development of the *T. brucei* receptor. First, perhaps to evade toxic components of the blood meal or to avoid niche competition with other trypanosome species in the proboscis, the developmental cycle of *T. brucei* altered, with the epimastigotes adopting a new location in the salivary glands, rather than developing in the mouthparts. As no haemoglobin is available from bloodmeals in the salivary glands, the receptor became redundant. A new pattern of expression then evolved in which the receptor was expressed in bloodstream forms instead of in epimastigotes. This switch conferred the ability to more efficiently acquire haem more efficiently in the bloodstream form. That this provides an advantage is evidenced by the attenuation of growth of a TbHpHbR null mutant in a mouse model ([@bib51]). However, free haemoglobin is not normally present in blood, where it rapidly assembles into HpHb complexes ([@bib53]; [@bib8]). Evolutionary changes therefore took place in TbHpHbR that resulted in an increase in its affinity for HpHb, from 8 μM in *T. congolense* to 1 µM in *T. brucei* ([@bib19]). A decrease in expression levels and a change in primary location from the cell surface to being concentrated in the flagellar pocket ([@bib51]) was most likely a final adaptation, perhaps driven by the need to avoid detection by the mammalian acquired immune system.

The change in the developmental stage of expression also had significant effects on the structure of the receptor. On the epimastigote surface, TcHpHbR is free to interact with its ligand relatively unimpeded by other surface proteins. In addition, with a 3 nM affinity for Hb, monovalent binding will allow efficient uptake, and simple tilting of the receptor around its GPI-anchor will position the binding site to allow simultaneous binding of two receptors to one Hb if required ([Figure 7](#fig7){ref-type="fig"}). A switch to expression in the bloodstream form forced the receptor to function within the densely packed VSG layer. In addition, switching to a ligand with approximately 1000-fold weaker binding made bivalent binding important for efficient uptake. To operate in this new context, the *T. brucei* receptor evolved by gaining both a novel C-terminal domain that probably increases the distance of the ligand binding site from the plasma membrane and by evolving a significant kink between the ligand-binding site and the membrane surface ([@bib29]; [@bib46]). This kink pushes the VSG molecules apart and presents the ligand-binding site at the surface. It also allows two receptors, both coupled to the membrane surface, to simultaneously bind to a single dimer of haptoglobin-haemoglobin, increasing avidity and uptake efficiency. A consequence of these changes was the loss of haemoglobin binding, which was no longer under positive selection.10.7554/eLife.13044.016Figure 7.A comparison of ligand binding by HpHbRs from different species.Space filling models of (**A**) Two TcHpHbR molecules binding to a single haemoglobin tetramer. (**B**) Two TbHpHbRs bound to a single haptoglobin-haemoglobin dimer.**DOI:** [http://dx.doi.org/10.7554/eLife.13044.016](10.7554/eLife.13044.016)

The evolution of the receptor has continued as some primates have acquired innate immune factors that kill trypanosomes. These trypanolytic factors, TLF1 and TLF2, exploit TbHpHbR to increase the efficiency of TLF uptake into *T. brucei* ([@bib5]). For the majority of African trypanosomes this has had a minor effect on parasite survival as non-primates, which lack TLFs, are their predominant hosts ([@bib21]). However, in *T. brucei gambiense*, the one subspecies that has evolved to infect humans as the main host, the receptor has responded to this new selection pressure through a point mutation that reduces affinity for TLF1 and HpHb ([@bib19]; [@bib7]; [@bib47]).

Therefore, the haptoglobin-haemoglobin receptor of African trypanosomes has undergone a remarkable set of adaptations in its co-evolution with its hosts. It has changed from an epimastigote-expressed haemoglobin receptor into a haptoglobin-haemoglobin receptor, expressed in the bloodstage of *T. brucei* and has adapted to function efficiently in its new surface environment. With an important role at the host-parasite interface, and as a target of innate immunity, it continues to evolve and adapt, allowing it to provide the parasite with a source of haem, while evading destruction by innate immunity factors.

Materials and methods {#s4}
=====================

Cloning of *T. vivax* HpHbR {#s4-1}
---------------------------

The gene TvY486 0024220 (tritrypdb.org) was identified as the closest homologue to *T. congolense* HpHbR using Blastp. The putative N-terminal signal sequence cleavage site was identified using SignalP ([@bib35]) and the putative C-terminal GPI-anchor addition site was identified by comparison with other trypanosome GPI-anchored proteins. A coding sequence for the mature polypeptide open reading frame plus a Tobacco Etch Virus (TEV) protease site at the N-terminus was synthesised with codons optimised for expression in *E. coli* using the manufacturer's software (Geneart, Thermo Fisher Scientific, Waltham MA) and was cloned into the NdeI and BamHI sites of pET15b.

HpHbR expression and purification {#s4-2}
---------------------------------

The *T. b. brucei* HpHbR N-terminal domain and *T. congolense* HpHbR had been previously cloned for expression into a modified pET-15b to include N-terminal hexahistidine tags and cleavage sites for TEV protease ([@bib29]; [@bib19]). To prepare receptors suitable for coupling to a surface plasmon resonance chip, sequences encoding biotin acceptor peptides (BAP) were cloned onto the C-termini of TbHpHbR, TcHpHbR and TvHpHbR.

All three receptors were expressed in *E. coli* Origami B cells. These were induced with 1 mM IPTG (Melford, UK) and incubated for 3 hr at 30°C for TcHpHbR and TvHpHbR, and overnight at 18°C for TbbHpHbR. The protein was purified by Ni^2+^-NTA affinity chromatography, followed by gel filtration using a Superdex 75 16/60 column (GE Healthcare, UK) in 20 mM HEPES pH 7.5, 150 mM NaCl. Protein used in crystallography experiments was cleaved overnight with His-tagged TEV protease at 4°C in 20 mM sodium phosphate pH 7.4, 150 mM NaCl, 3 mM oxidised glutathione, 0.3 mM reduced glutathione to remove the N-terminal His-tag. This was followed by reverse Ni^2+^-NTA affinity chromatography prior to gel filtration.

HpSP expression, and HpHb complex purification {#s4-3}
----------------------------------------------

The SP domain of human haptoglobin had been previously cloned into a modified pAcGP67A vector to generate a polypeptide with an N-terminal hexahistidine tag and a cleavage site for TEV protease. This was expressed in Sf9 insect cells and purified by Ni^2+^-NTA affinity chromatography and gel filtration as described previously ([@bib29]). Full length, dimeric haptoglobin 1--1 was purchased (Sigma Aldrich, St Louis, MO). To purify haemoglobin, human blood was sonicated, followed by anion exchange chromatography using a Mono Q column (GE Healthcare). HpHb and HpSPHb were assembled and purified as described previously ([@bib29]).

Analytical gel filtration {#s4-4}
-------------------------

The assembly of complexes containing TcHpHbR and HpSPHb was assessed using analytical gel filtration chromatography. 0.2 mg of TcHpHbR and 0.3 mg of HpSPHb were mixed (\~4:3 molar ratio) before loading onto a Superdex 200 10/300 GL column (GE Healthcare). This was run using an ÄKTApurifier (GE Healthcare) in 20 mM HEPES pH 7.5, 150 mM NaCl.

Trypanosome cell culture {#s4-5}
------------------------

*T. congolense* IL3000 bloodstream form cells were grown in TcBSF-1 media at 37°C with 5% CO~2~. *T. congolense* IL3000 procyclic form cells were grown in TcPCF-3 media at 27°C with 5% CO~2~ ([@bib6]). *T. congolense* procyclic and epimastigote form cells derived from isolates Gam 2 and WG81 were grown in Cunningham's medium (CM) at 27°C. In order to generate epimastigotes, procyclic form cultures were maintained at stationary phase by replacing half of the culture medium every three to four days ([@bib6]). Differentiation to epimastigotes occurred in these cultures after 1--3 months. Epimastigotes were identified by adherence to the culture flask and repositioning of the kinetoplast from posterior and distal to the nucleus, to a position either proximal or anterior to the nucleus. Attempts to harvest the adherent epimastigotes using a cell scraper resulted in damaged/destroyed cells. Some epimastigotes could be dislodged into the supernatant by washing the flask several times with the culture supernatant. Western blots were therefore carried out on the supernatant of these cultures containing both trypomastigote and epimastigote forms.

*T. brucei* TbHpHbR KO bloodstream form cells ([@bib29]) were grown in HMI-9 with 10% FCS at 37°C with 5% CO~2~ ([@bib20]). The TcHpHbR was inducibly overexpressed in *T. brucei* TbHpHbR KO BSFs transfected with pSMOX ([@bib36]) and a modified version of pDEX777 (also [@bib36]) where the GFP ORF was replaced with the TcHpHbR ORF. Cells were induced with 10 µg/ml doxycycline for 24 hr before protein was harvested and analysed by western blot.

Tsetse fly infection and dissection {#s4-6}
-----------------------------------

Experimental tsetse flies (*Glossina pallidipes)* were caged in groups of 15, kept at 25°C and 70% relative humidity, and fed on sterile defibrinated horse blood supplemented with 1 mM dATP ([@bib15]) via a silicone membrane. Male and female flies were used for experiments, being given the infective bloodmeal for their first feed 24--48 hr post-eclosion. The infective feed contained approximately 1 x 10^6 ^*T. congolense* Gam 2 trypanosomes ml^-1^ from the supernatant of epimastigote cultures in washed red blood cells supplemented with 10 mM L-glutathione ([@bib31]) to increase infection rates.

Flies were dissected 40--42 days post infection. Heads were removed and proboscides dissected directly into a drop of vPBS on assay slides, carefully separating apart the labrum, hypopharynx and labium. Whole tsetse alimentary tracts were dissected and the proventriculus and midgut placed into separate drops of vPBS.

Analysis of TcHpHbR protein expression in *T. congolense* epimastigotes {#s4-7}
-----------------------------------------------------------------------

Western blot analysis was carried out on cell lysates using standard methods. Bloodstream and procyclic form cell lysates were harvested from *T. congolense* Il3000 cells from log-phase cultures. Epimastigote cell lysates were collected from three independently generated epimastigote-containing cultures.

Antibodies were raised by injecting recombinant TcHpHbR into rabbits (Covalab, France) and purified using affinity chromatographywith TcHpHbR agarose.

Quantification of the copy number of TcHpHbR was carried out by western blot and comparison between cell lysates and recombinant protein. To determine the number of cells expressing TcHpHbR in the samples, six IFAs were carried out (as described below) and 500 cells per IFA were scored as positive or negative for TcHpHbR expression. A total of 50/3000 cells, or 1.67% of the population, were positive for TcHpHbR expression. By comparison with known quantities of recombinant TcHpHbR protein on two independent western blots it was observed that 8.35 x 10^4^ TcHpHbR-expressing cells was equivalent to 2.25--4.5 ng protein, or 4.6 and 9.3 x 10^5^ molecules per cell, using a molecular weight of 35 kDa for calculations.

Immunofluorescent analysis of culture-generated epimastigotes was carried out on culture supernatants as described above or on cells grown on glass coverslips to enrich for the adherent epimastigotes. Cells were either fixed with 4% paraformaldehyde at room temperature for 30 min and then blocked with 10 mM methylamine-HCl pH 8.0 for 30 min or fixed by air-drying and then incubating in ice-cold methanol for 30--60 min. Samples were blocked with 5% donkey serum in PBS for 1 hr. Cells were then incubated for 1 hr with rabbit anti-TcHpHbR polyclonal antisera raised against recombinant TcHpHbR protein followed by an Alexa488 donkey anti-rabbit secondary antibody diluted in 5% serum in PBS, also for 1 hr. Cells were stained with 1 µg/ml DAPI for 5 min, washed and mounted with Calbiochem FluorSave Reagent (Merck Millipore, Billerica, MA). For immunofluorescent analysis of tsetse-derived *T.congolense*, dissected samples were air-dried and fixed in ice-cold methanol for 30 min, then processed as above. Microscopy was carried out on a Zeiss Imager M1 microscope and analysed with AxioVision Rel 4.8 software.

Analysis of ligand uptake into *T. congolense* epimastigotes {#s4-8}
------------------------------------------------------------

Hb and BSA were labelled with Alexa Fluor 488 using a protein labelling kit (Thermo Fisher Scientific). *T. congolense* WG81 epimastigote-containing cultures (generated as above) were grown on coverslips overnight in serum-free Cunningham's media supplemented with 5 mg/ml BSA, 1 mM hypoxanthine and 0.16 mM thymidine. Incubation in serum-free media was required to remove competing Hb ligand from the media. Coverslips were moved onto poly-l-lysine slides and incubated with no ligand, 10 nM Hb-488 or 10 nM-BSA at 27°C for 4 hr. At 2 hr post-addition of ligand, 2 µM protease inhibitor FMK-024 was added. Cells were fixed in 4% paraformaldehyde for 30 min at room temperature, washed 3x in PBS, stained with 1 µg/ml DAPI for 5 min and mounted. Microscopy was carried out as above.

Crystallisation, data collection and structure determination {#s4-9}
------------------------------------------------------------

HpSPHb and TcHpHbR were mixed in equimolar ratios to a final total concentration of 12.5 mg/ml in 20 mM HEPES pH 7.5, 150 mM NaCl and were subjected to crystallisation trials. Crystals were obtained after 18 hr in a sitting drop format with a well solution containing 0.1 M sodium citrate pH 5, 8% w/v PEG 8000. After cryoprotection by transfer into well solution with the addition of 30% glycerol, the crystals were cryo-cooled. Data were collected on beamline I03 at the Diamond light source and were indexed and scaled using iMosflm ([@bib1]) and Scala ([@bib12]) respectively. Phaser ([@bib32]) was used to determine a molecular replacement model, using the known structures of TcHpHbR (pdb: 4E40, [@bib19]) and human oxygenated Hb (pdb: 1HHO, [@bib42]) as search models. Refinement and rebuilding was completed using Buster ([@bib4]) and Coot ([@bib10]) respectively.

Surface plasmon resonance {#s4-10}
-------------------------

Receptors were coupled to an SPR chip using a biotin attached to the C-terminal BAP tag. This strategy was designed to allow them to be immobilised with an orientation matching that found on the parasite surface, and to generate a surface that could be readily regenerated. Purified receptors were biotinylated by mixing 1 mg of protein at 30 μM with 20 μg of BirA (Sigma Aldrich), 5 mM ATP (Sigma Aldrich) and 300 μM biotin (Sigma Aldrich). They were incubated at room temperature overnight, before desalting using a PD10 column (GE Healthcare) to remove excess biotin.

SPR experiments were carried out on a Biacore T200 instrument (GE Healthcare). All experiments were performed in 20 mM HEPES pH 7.5, 150 mM NaCl, 0.005% Tween-20 at 25°C. Two-fold dilution series of human Hb, human HpHb or bovine Hb (Sigma) were prepared for injection over a receptor-coated chip with upper concentrations of 1 μM. For each cycle, biotinylated recombinant receptor was immobilised on a CAP chip using the Biotin CAPture Kit (GE Healthcare) to a total loading of \~250 RU. Binding partners were injected for 240 s with a dissociation time of 300 s. The chip was regenerated between cycles using regeneration solution from the Biotin CAPture Kit. The specific binding response of the ligands to receptors was determined by subtracting the response given by Hb or HpHb from a surface to which no receptor had been coupled. As both Hb and HpHb have the capacity to simultaneously interact with two receptors, this data was not fitted to obtain affinity measurements.

Isothermal titration calorimetry {#s4-11}
--------------------------------

ITC measurements were carried out on a MicroCal iTC200 System (Malvern, UK). Samples were dialysed for 15 hr into 20 mM HEPES pH 7.5, 150 mM NaCl at 4°C. Experiments were performed at 25°C with 50 μl of *T. congolense* HpHbR at 250 μM titrated into a cell containing 300 μl of Hb at 18 μM. The titrant was injected in 20 injections of 2 μl. Data were integrated and fit by nonlinear least-squares fitting using Origin ITC Software (Malvern).
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Thank you for submitting your work entitled \"Evolutionary diversification of the trypanosome haptoglobin-haemoglobin receptor\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by Dominique Soldti-Favre as the Reviewing Editor and Richard Losick as the Senior Editor.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

The following individuals involved in the review of your submission have agreed to reveal their identity: Michael Ferguson and Søren Moestrup (peer reviewers).

Summary:

This study convincingly establishes that *Trypanosoma congolense* haptoglobin haemoglobin receptor (TcHpHbR) acts primarily as a high affinity haemoglobin receptor in the epimastigote developmental stage. Surface Plasmon Resonance analysis showed the *T. congolense* and *T. vivax* HpHbR bound both HpHb and Hb but formed a far more stable complex with Hb alone. Based on these observations, the authors suggest that this receptor is tailored for the epimastigote forms to scavenge haemoglobin in the fly. Consistent with a role in the insect vector they found that the HpHbR is not expressed in bloodstream forms but rather in the epimastigote stage found attached to the proboscis. Further, based on IFA and western blot analysis they predict greater than 5 X 105 receptors distributed rather uniformly across the cell surface. Analysis of the structure of the TcHpHbR with bound Hb provided a clear understanding of the features that mediate this high affinity receptor-ligand interaction.

The authors further hypothesize that this ancestor receptor diverged during *T. brucei* evolution giving rise to the HpHb binding properties of the *T. brucei* HpHbR. In *T. brucei*, this receptor evolved to gain distance between ligand binding site and the membrane and also a kink to exclude VSG interactions. Importantly the receptor has morphed into a different shape and specificity to preferentially bind HpHb to satisfy the organisms need for iron -- with the complication of host-range modulation through *Trypanosoma* lytic factor uptake.

Overall, this is a well-written paper with important findings that add significantly to our understanding of the crucial interplay between trypanosomes and host haemoglobin.

Essential revisions:

1\) The title may suggest that this is a phylogenetic study but it is in fact far more than that. The finding that the ancestral receptor binds the Hb tetramer as shown in the beautiful 3D structure is a key observation that should be included. For instance, \'Evolutionary diversification of the trypanosome haemoglobin-haptoglobin receptor from an ancestral haemoglobin receptor\'.

2\) Abstract, last sentence. This statement concerning the host immune defence against the *T. brucei* has little relevance for the present study and is confusing for the reader not familiar with the complex innate primate immune response. Further, the reason that some species can overcome this immune response and thereby become human infective is due to another line of evolution in the parasites than described here (evolvement of resistance proteins, mutations etc.).

3\) Results: subsection "The *T. brucei* haptoglobin-haemoglobin receptor has evolved from a haemoglobin receptor", first paragraph: The interaction between human Hp and Hb is extremely strong (K~D~ = 10-15). The authors show that TcHpHbR is capable of dissociating the HpSP-Hb complex. However, the HpSP used in these experiments was expressed in insect cells and not processed correctly into α- and β-chains. Consequently, the recombinant HpSP may have a much lower affinity for Hb compared to native Hp. The authors should investigate if TcHpHbR can also dissociate native Hp-Hb. If TcHpHbR is in fact able to dissociate the native Hp-Hb complex, this suggest the TcHpHbR is entirely an Hb receptor and when it encounters an Hp-Hb complex it can wrest Hb from Hp and only take up Hb.

4\) Results: subsection \"The haptoglobin-haemoglobin receptor of *T. congolense* is expressed in the epimastigote developmental stage", third paragraph: It would be relevant to show that the in vitro-generated epimastigote forms that express the receptor bind Hb. Further, it would be relevant to investigate whether they take up Hb or use it as a kind of coating as discussed later.

5\) [Figure 1](#fig1){ref-type="fig"}: Only human Hb is tested to the *T. congolense* receptor. In view of the structural data suggesting that Hb from other species may bind equally well, it would be relevant to include binding data of other species, e.g. rodent and bovine Hb.

6\) Cattle and deer have multimeric Hp due to a duplication of the CCP domain. This may allow the Hp-Hb complexes to bind multiple receptors on the surface of the parasites. The authors should comment on how this may affect the claimed preference of TcHpHbR for Hb over Hp-Hb.

7\) Results: subsection "The structural basis for haemoglobin binding", second paragraph: The authors describe that TcHpHbR interacts both the α- and β-subunits of tetrameric Hb. From [Figure 4](#fig4){ref-type="fig"} it is evident that TcHpHbR binds Hb across the dimer-dimer interface and contacts α1/β2 or α2/β1. This is quite interesting because it suggests that TcHpHbR have evolved to recognize only tetrameric Hb or that the Hb tetramer is perhaps formed on the receptor as a result of interaction with separate Hb dimers. The authors should comment on this.

8\) Results: subsection "The structural basis for haemoglobin binding", third paragraph: The propionate side chains of both Hb subunits are recognized by TcHpHbR. A detailed figure showing these interactions should be included in [Figure 4](#fig4){ref-type="fig"}.

9\) Results: subsection "The structural basis for haemoglobin binding", fourth paragraph. A model of the Hp-Hb interaction with TcHpHbR is presented in [Figure 5](#fig5){ref-type="fig"}. The statement that \"Hp is capable of forming a close interaction with TcHpHbR\" should be supported by a detailed figure either as a panel in [Figure 5](#fig5){ref-type="fig"} or as supplement. Is this interaction expected to involve similar contacts as those observed in the TbHpHbR-HpHb structures?

10\) Western blots showed two anti-TcHpHb reactive bands, neither at the expected size for unmodified TcHpHb. Since the recombinant TcHpHb runs with the lower, less abundant band this would be consistent with glycosylation differences but this is not shown. The reason for concern is that no evidence is presented to show that the upper band is not an unrelated cross-reactive protein.

11\) The IFA images clearly show that a sub-population in the cultures react with that anti-TcHpHb. From these images the authors indicate that all cells where kinetoplast repositioning had occurred reacted with the antibody. Unfortunately, the quality of the images and lack of labeling makes it difficult to see the relationship. Perhaps more important is that based on these images alone the authors conclude that TcHpHb is distributed across the cell surface. However, since the cells were alcohol fixed it remains possible that the IFA is also revealing intracellular protein. Experiments to demonstrate cell surface localization should be straightforward.

12\) Discussion: The evolution of the trypanosome receptor from a Hb receptor to a Hp-Hb receptor may go in line with the development of an extended role of Hb as a protein protecting against Hb toxicity in mammalians. Furthermore, there is an interesting parallel between the present data and other date indicating the development of the human Hp-Hb receptor CD163 from a phylogenetic older Hb binding CD163 in mammals -- and perhaps also from an older similar to the Hb-binding Pit54 protein in birds (last paragraph in discussion, Etzerodt et al. Antiox. Redox Sign. 18: 2254-63 (2013) and Wicher and Fries PNAS 103:4168-73 (2006)).

13\) The role of TcHpHb during the life cycle of the parasite should be more extensively discussed.

13.1) In particular, the role of this receptor in haem acquisition by *T. congolense* is proposed but there is no mention of how, in the absence of the TcHpHbR, the bloodstream and procyclic trypanosomes might acquire haem. If the authors porpose that *T. congolense* and *T. vivax* use transferrin receptors for iron, why does *T. brucei* need a transferrin receptor when it should be able to get iron in the form of haem via the HpHb receptor? How do the authors see the Tc and Tv surviving in the fly when they would be dependent on the fly\'s blood-meal -- would that be frequent enough? -- some discussion may be warranted.

13.2) The authors discuss the role of the TbHpHbR in susceptibility to trypanosome lytic factors, however, they clearly show that the HpHbR is not expressed in human serum susceptible bloodstream *T. congolense*. This might be elaborated on.

10.7554/eLife.13044.018

Author response

Essential revisions:

*1) The title may suggest that this is a phylogenetic study but it is in fact far more than that. The finding that the ancestral receptor binds the Hb tetramer as shown in the beautiful 3D structure is a key observation that should be included. For instance, \'Evolutionary diversification of the trypanosome haemoglobin-haptoglobin receptor from an ancestral haemoglobin receptor\'.*

We have changed the title as suggested to 'Evolutionary diversification of the trypanosome haptoglobin-haemoglobin receptor from an ancestral haemoglobin receptor'.

2\) Abstract, last sentence. This statement concerning the host immune defence against the T. brucei has little relevance for the present study and is confusing for the reader not familiar with the complex innate primate immune response. Further, the reason that some species can overcome this immune response and thereby become human infective is due to another line of evolution in the parasites than described here (evolvement of resistance proteins, mutations etc.).

As suggested, we have removed the final sentence of the Abstract.

3\) Results: subsection "The T. brucei haptoglobin-haemoglobin receptor has evolved from a haemoglobin receptor", first paragraph: The interaction between human Hp and Hb is extremely strong (K~D~ = 10-15). The authors show that TcHpHbR is capable of dissociating the HpSP-Hb complex. However, the HpSP used in these experiments was expressed in insect cells and not processed correctly into α- and β-chains. Consequently, the recombinant HpSP may have a much lower affinity for Hb compared to native Hp. The authors should investigate if TcHpHbR can also dissociate native Hp-Hb. If TcHpHbR is in fact able to dissociate the native Hp-Hb complex, this suggest the TcHpHbR is entirely an Hb receptor and when it encounters an Hp-Hb complex it can wrest Hb from Hp and only take up Hb.

At the start of the Results section of our manuscript we describe an experiment in which we mixed *T. congolense* HpHbR with human HpSPHb complex and observed this to result in the formation of a complex of TcHpHbR with Hb and free HpSP. We describe this experiment as it was the observation that led to our discovery that TcHpHbR is an Hb receptor, rather than to imply that TcHpHR will disassemble HpHb as part of its physiological function. As the reviewers rightly point out, the HpSPHb used in this experiment is not identical to native HpHb complex, as native Hp is cleaved into α and β chains. While structural alignments show that this does not affect the position of residues involved in the interaction with the haptoglobin-haemoglobin receptors, it does alter the interface between Hp and Hb and could change the stability of the HpHb complex. We therefore performed the experiment suggested by the reviewers in which we incubated HpHb with TcHpHbR, and in this case we do not see disassembly of the HpHb. However, neither do we see the formation of a TcHpHbR:HpHb complex with sufficient stability to survive gel filtration chromatography. This is in contrast to what occurs when we mix TcHpHbR with Hb, when a stable complex is formed. This data is now presented in [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}. This supports our conclusion that TcHpHbR is primarily an Hb receptor and also shows that it is unlikely that TcHpHbR can disassemble HpHb during the acquisition of haem.

*4) Results: subsection \"The haptoglobin-haemoglobin receptor of T. congolense is expressed in the epimastigote developmental stage", third paragraph: It would be relevant to show that the in vitro-generated epimastigote forms that express the receptor bind Hb. Further, it would be relevant to investigate whether they take up Hb or use it as a kind of coating as discussed later.*

The reviewers asked for further experiments in which we test the functional consequences of the expression of the receptor to see whether *T. congolense* epimastigotes can internalise haemoglobin or whether a coat of haemoglobin assembles on the parasite surface. Culture-derived epimastigotes were therefore incubated with fluorescently-labelled human haemoglobin. These data (now presented in [Figure 4](#fig4){ref-type="fig"}) show clear internalisation of the labelled haemoglobin into epimastigotes, while there is no internalisation into trypomastigotes. In contrast, we did not observe any accumulation of labelled haemoglobin on the cell surface in these experiments. We have therefore confirmed that the *T. congolense* epimastigotes can use TcHpHbR to allow them to internalise haemoglobin.

5\) [Figure 1](#fig1){ref-type="fig"}: Only human Hb is tested to the T. congolense receptor. In view of the structural data suggesting that Hb from other species may bind equally well, it would be relevant to include binding data of other species, e.g. rodent and bovine Hb.

The reviewers point out that the original manuscript showed only the binding of TcHpHbR to human haemoglobin. As *T. congolense* is not human infective, they ask for confirmation that it also binds to haemoglobins from other species. In the original manuscript we presented a figure (Figure 4---figure supplement 1) showing that the haemoglobin residues that contact TcHpHbR are absolutely conserved between human and bovine haemoglobin. In this revised version we make two additions. We show experimentally that TcHpHbR does indeed interact with bovine Hb, with an affinity similar to that of human Hb, and we describe this data in the fourth paragraph of the subsection "The *T. brucei* haptoglobin-haemoglobin receptor has evolved from a haemoglobin receptor". This is presented in [Figure 1---figure supplement 2](#fig1s2){ref-type="fig"}). We also increase the range of species (all known to be infected by *T. congolense*) included in Figure 4---figure supplement 1, showing that the residues contacted by *T. congolense* are conserved in cows, sheep, horses and camels.

6\) Cattle and deer have multimeric Hp due to a duplication of the CCP domain. This may allow the Hp-Hb complexes to bind multiple receptors on the surface of the parasites. The authors should comment on how this may affect the claimed preference of TcHpHbR for Hb over Hp-Hb.

The reviewers mention that Hp from bovine and deer adopt higher order multimers than those present in the dimeric HpHb used in this study, and that this might increase the efficiency of uptake of HpHb. This is possible, although it is also possible that the arrangement of the binding sites in the larger HpHb complexes might not allow increased binding to receptors associated with the parasite surface for steric reasons. We have added a sentence in the second paragraph of the Discussion to raise this issue for the reader.

*7) Results: subsection "The structural basis for haemoglobin binding", second paragraph: The authors describe that TcHpHbR interacts both the α- and β-subunits of tetrameric Hb. From [Figure 4](#fig4){ref-type="fig"} it is evident that TcHpHbR binds Hb across the dimer-dimer interface and contacts α1/*β*2 or α2/*β*1. This is quite interesting because it suggests that TcHpHbR have evolved to recognize only tetrameric Hb or that the Hb tetramer is perhaps formed on the receptor as a result of interaction with separate Hb dimers. The authors should comment on this.*

The reviewers ask whether the structure suggests that the receptor only interacts with a haemoglobin tetramer or whether two haemoglobin dimers can assemble together on the receptor. In the absence of affinity measurements for the haemoglobin dimer (which would require a stabilised haemoglobin dimer) we cannot present the quantitative analysis that we would have liked to include. However, we speculate that either is possible in the second paragraph of the subsection "The structural basis for haemoglobin binding".

8\) Results: subsection "The structural basis for haemoglobin binding", third paragraph: The propionate side chains of both Hb subunits are recognized by TcHpHbR. A detailed figure showing these interactions should be included in [Figure 4](#fig4){ref-type="fig"}.

As suggested, we have remodelled the original [Figure 4](#fig4){ref-type="fig"}, now [Figure 5](#fig5){ref-type="fig"}, removing panels B and E and replacing them with close up views of the interactions that TcHpHbR makes with the haem groups of the haemoglobin α- and β-chains.

9\) Results: subsection "The structural basis for haemoglobin binding", fourth paragraph. A model of the Hp-Hb interaction with TcHpHbR is presented in [Figure 5](#fig5){ref-type="fig"}. The statement that \"Hp is capable of forming a close interaction with TcHpHbR\" should be supported by a detailed figure either as a panel in [Figure 5](#fig5){ref-type="fig"} or as supplement. Is this interaction expected to involve similar contacts as those observed in the TbHpHbR-HpHb structures?

To illustrate our model of the TcHpHbR:HpHb complex we have added a second view, taken from the bottom of the receptor, to [Figure 6](#fig6){ref-type="fig"} (originally [Figure 5](#fig5){ref-type="fig"}). This will show, in more detail, how close the loops of Hp come to the receptor in this configuration. In addition, the interaction between TbHpHbR and Hp in the TbHpHbR:HpHb complex is mostly hydrophobic in nature and we now point out that a similar, but smaller, hydrophobic patch is present in TcHpHbR, centred around Phe48, which can mediate an equivalent hydrophobic interaction with Hp. We prefer not to show the model in further detail (for example showing the side chains) as this would be an over-interpretation of the model. Instead it is presented to support our hypothesis that the β-subunit of Hb will interact with the upper binding site on TcHpHbR when it binds to the HpHb complex.

10\) Western blots showed two anti-TcHpHb reactive bands, neither at the expected size for unmodified TcHpHb. Since the recombinant TcHpHb runs with the lower, less abundant band this would be consistent with glycosylation differences but this is not shown. The reason for concern is that no evidence is presented to show that the upper band is not an unrelated cross-reactive protein.

The reviewers also asked for some further experiments to confirm that the bands recognised by anti-TcHpHbR are not reacting with an unrelated protein. This comment was stimulated by the higher molecular weight of the antibody reactive band in the epimastigotes when compared with recombinant protein. In the absence of an epimastigote form of a *T. congolense* HpHbR^-/-^ cell line, we tested this using *T. brucei* TbHpHbR^-/-^ bloodstream forms carrying an inducible copy of a TcHpHbR transgene. Upon induction with doxycycline, the antisera detected two bands that again ran at a higher molecular weight than the recombinant TcHpHbR. This data is presented in [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"} and shows that a fraction of *T. brucei* expressed TcHpHbR runs in the same position as the antibody-reactive band in the epimastigotes. This difference in mobility is probably due to differential modification of GPI-anchors in the bloodstream and insect cell stages of *T. brucei*. The insect stages are modified with sialic acid residues whereas the bloodstream forms, used here for the transgene expression, are not. In conjunction with our new data showing haemoglobin uptake into *T. congolense* epimastigotes, this gives strong support to our conclusion that TcHpHbR is expressed in epimastigotes.

*11) The IFA images clearly show that a sub-population in the cultures react with that anti-TcHpHb. From these images the authors indicate that all cells where kinetoplast repositioning had occurred reacted with the antibody. Unfortunately, the quality of the images and lack of labeling makes it difficult to see the relationship. Perhaps more important is that based on these images alone the authors conclude that TcHpHb is distributed across the cell surface. However, since the cells were alcohol fixed it remains possible that the IFA is also revealing intracellular protein. Experiments to demonstrate cell surface localization should be straightforward.*

To confirm that the TcHpHbR is surface localised, we have collected further IFA images of epimastigotes, both culture-derived and dissected from tsetse flies. We have also conducted imaging experiments using paraformaldehyde-fixed, non-permeabilised cells. We see clear surface staining in both the permeabilise and non-permeabilised cells, clearly indicating surface localisation. We also confirm this in tsetse-derived epimastigotes, showing that receptor expression in eptimastigotes is not a consequence of in vitro differentiation. This data is now presented in a revised version of [Figure 3](#fig3){ref-type="fig"}.

12\) Discussion: The evolution of the trypanosome receptor from a Hb receptor to a Hp-Hb receptor may go in line with the development of an extended role of Hb as a protein protecting against Hb toxicity in mammalians. Furthermore, there is an interesting parallel between the present data and other date indicating the development of the human Hp-Hb receptor CD163 from a phylogenetic older Hb binding CD163 in mammals -- and perhaps also from an older similar to the Hb-binding Pit54 protein in birds (last paragraph in discussion, Etzerodt et al. Antiox. Redox Sign. 18: 2254-63 (2013) and Wicher and Fries PNAS 103:4168-73 (2006)

We thank the referees for pointing out the interesting parallels in changes in ligand specificity between published findings on CD163 and our findings. We have mentioned these in the Results section (subsection "The *T. brucei* haptoglobin-haemoglobin receptor has evolved from a 149 haemoglobin receptor", fourth paragraph) and by the addition of Etzerodt et al. in the references section. While the changes in the specificity of CD163 are interesting, we do not believe that there is evidence to suggest that these changes are related to the changes in specificity of HpHbR in their functional consequence, as alterations in HpHbR specificity correlated with a change in life cycle stage usage.

13\) The role of TcHpHb during the life cycle of the parasite should be more extensively discussed.

13.1) In particular, the role of this receptor in haem acquisition by T. congolense is proposed but there is no mention of how, in the absence of the TcHpHbR, the bloodstream and procyclic trypanosomes might acquire haem. If the authors porpose that T. congolense and T. vivax use transferrin receptors for iron, why does T. brucei need a transferrin receptor when it should be able to get iron in the form of haem via the HpHb receptor? How do the authors see the Tc and Tv surviving in the fly when they would be dependent on the fly\'s blood-meal -- would that be frequent enough? -- some discussion may be warranted.

We agree with the reviewers that the switch in expression stage of HpHbR leads to a number of questions. We have speculated in the manuscript (Discussion, third paragraph) that the high expression level of TcHpHbR is present to allow capture of Hb from the blood meal as it flows through the mouthparts of the tsetse fly and that lower expression levels are acceptable in the mammalian bloodstream where the parasite is more continuously exposed to HpHb and so does not need a transient capture mechanism. This adaptation might allow the parasite to acquire sufficient haem during its time in the tsetse fly, but an experimental demonstration of this will be challenging. It is also possibility that there are other mechanisms by which *T. congolense* acquires haem in the mammalian bloodstream, as not discussed in the aforementioned paragraph.

13.2) The authors discuss the role of the TbHpHbR in susceptibility to trypanosome lytic factors, however, they clearly show that the HpHbR is not expressed in human serum susceptible bloodstream T. congolense. This might be elaborated on.

We have also implied that the susceptibility to trypanolytic factors will have been increased as a result of the switch in expression of HpHbR to the blood stream in our Discussion (for example in the sixth paragraph). However, the other methods for HpHbR-independent uptake of trypanolytic factors into trypanosomes mean that we prefer not to discuss this point at length.

[^1]: These authors contributed equally to this work.
